Pathobiological Implications of MUC16/CA125 Expression in Intrahepatic Cholangiocarcinoma-Mass Forming Type

被引：80
|
作者：
Higashi, Michiyo [1 ]
Yamada, Norishige [1 ]
Yokoyama, Seiya [1 ]
Kitamoto, Sho [1 ]
Tabata, Kazuhiro [1 ]
Koriyama, Chihaya [2 ]
Batra, Surinder K. [3 ,4 ]
Yonezawa, Suguru [1 ]
机构：
[1] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human Pathol, Field Oncol, Kagoshima 8908544, Japan
[2] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Epidemiol & Prevent Med, Kagoshima 8908544, Japan
[3] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Dept Biochem, Omaha, NE USA
[4] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Dept Mol Biol, Omaha, NE USA
来源：
PATHOBIOLOGY | 2012年 / 79卷 / 02期
关键词：
Cholangiocarcinoma; MUC16; CA125; Prognosis; PROGNOSTIC-FACTOR; EXTRACELLULAR SUPERSTRUCTURE; SURGICAL-TREATMENT; CA-125; GENE; MUC4; MUCINS; CA125; NEOPLASMS; CARCINOMA; DIAGNOSIS;
D O I：
10.1159/000335164
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Objectives: MUC16 carries the peptide epitope CA125, which is well known as a marker of ovarian cancer. High serum levels of MUC16 (CA125) have been reported not only in patients with ovarian cancer but also in patients with liver diseases. We evaluated the expression of MUC16 in intrahepatic cholangiocarcinoma-mass forming type (ICC-ME) tissues. Methods: We examined the expression of MUC16 by immunohistochemical analyses using the monoclonal antibody M11 in ICC-MF tissues from 63 patients. To compare the prevalence of each mucin expression by clinicopathological features, appropriate statistical analysis was performed. Results: MUC16 was detected in 48% of samples (30/63). After adjusting for the effects of other prognostic factors, multi-variate survival analysis revealed that MUC16 expression is a significant independent factor of poor prognosis (p = 0.005). Conclusion:The current results indicate that MUC16 expression is a prognostic factor of poor survival in ICC-MF. Copyright (C) 2012 S. Karger AG, Basel
引用
收藏
页码：101 / 106
页数：6
相关论文
共 50 条
  • [1] Pathobiological Role of MUC16 (CA125) in Pancreatic Cancer
    Haridas, D.
    Chakraborty, S.
    Ponnusamy, M. P.
    Lakshmanan, I.
    Rachgani, S.
    Cruz, E.
    Kumar, S.
    Lele, S. M.
    Anderson, J. M.
    Wittel, U. A.
    Hollingsworth, M. A.
    Batra, S. K.
    PANCREAS, 2011, 40 (08) : 1325 - 1325
  • [2] Expression of MUC16/CA125 Is Associated with Impaired Survival in Patients with Surgically Resected Cholangiocarcinoma
    Kinzler, Maximilian N.
    Schulze, Falko
    Gretser, Steffen
    Abedin, Nada
    Trojan, Joerg
    Zeuzem, Stefan
    Schnitzbauer, Andreas A.
    Walter, Dirk
    Wild, Peter J.
    Bankov, Katrin
    CANCERS, 2022, 14 (19)
  • [3] MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type
    Shibahara, H
    Tamada, S
    Higashi, M
    Goto, M
    Batra, SK
    Hollingsworth, MA
    Imai, K
    Yonezawa, S
    HEPATOLOGY, 2004, 39 (01) : 220 - 229
  • [4] Pathobiological Implications of MUC16 Expression in Pancreatic Cancer
    Haridas, Dhanya
    Chakraborty, Subhankar
    Ponnusamy, Moorthy P.
    Lakshmanan, Imayavaramban
    Rachagani, Satyanarayana
    Cruz, Eric
    Kumar, Sushil
    Das, Srustidhar
    Lele, Subodh M.
    Anderson, Judy M.
    Wittel, Uwe A.
    Hollingsworth, Michael A.
    Batra, Surinder K.
    PLOS ONE, 2011, 6 (10):
  • [5] A Binding Domain on Mesothelin for CA125/MUC16
    Kaneko, Osamu
    Gong, Lucy
    Zhang, Jingli
    Hansen, Johanna K.
    Hassan, Raffit
    Lee, Byungkook
    Ho, Mitchell
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (06) : 3739 - 3749
  • [6] MUC16/CA125 in cancer: new advances
    Zhang, Xin-Yu
    Hong, Lian-Lian
    Ling, Zhi-Qiang
    CLINICA CHIMICA ACTA, 2025, 565
  • [7] A Novel MUC16 (CA125) Monoclonal Antibody
    da Silva, L. Marcos
    Campos, D.
    Mandel, U.
    Bennett, E. P.
    Blixt, O.
    Levery, S. B.
    David, L.
    Clausen, H.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S42 - S42
  • [8] Pathobiological role of MUC16 mucin(CA125) in ovarian cancer: Much more than a tumor biomarker
    Alain Piché
    World Journal of Obstetrics and Gynecology, 2016, (01) : 39 - 49
  • [9] CA125/MUC16 Is Dispensable for Mouse Development and Reproduction
    Cheon, Dong-Joo
    Wang, Ying
    Deng, Jian Min
    Lu, Zhen
    Xiao, Lianchun
    Chen, Chun-Ming
    Bast, Robert C., Jr.
    Behringer, Richard R.
    PLOS ONE, 2009, 4 (03):
  • [10] Understanding the Unique Attributes of MUC16 (CA125): Potential Implications in Targeted Therapy
    Das, Srustidhar
    Batra, Surinder K.
    CANCER RESEARCH, 2015, 75 (22) : 4669 - 4674
12345